MXD: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection)

Product code MXD, “Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection)” in FDA's classification database, is a Class II device type under 21 CFR 870.1025 (arrhythmia detector and alarm (including ST-segment measurement and alarm)), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 34 clearances under MXD, 34 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
MXD
Regulation
21 CFR 870.1025
Class
II
Panel
Cardiovascular
Clearances
34
Most recent
Aug 28, 2026
Median review, last 2 years
30 days
Third-party review
Not eligible
Implant
Yes

What it covers

The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.

The identification in 21 CFR 870.1025, arrhythmia detector and alarm (including ST-segment measurement and alarm). FDA gives MXD no definition of its own, so the regulation’s describes it.

FDA flags MXD devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K262735LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)Medtronic, Inc.Aug 28, 2026Special
K261074BIOMONITOR IV (471155)Biotronik, Inc.May 1, 2026Special
K253516Assert-IQ (DM5100)ABBOTT MEDICALDec 18, 2025Special
K251221Assert-IQ (DM5000); Assert-IQ (DM5300); Assert-IQ (DM5500); Merlin.net (MN7000)AbbottSep 17, 2025Traditional
K252593LUX-Dx II Insertable Cardiac Monitor (M302); LUX-Dx II+ Insertable Cardiac Monitor (M312)Boston Scientific CorporationSep 12, 2025Special
K240693LINQ II™ Insertable Cardiac Monitor (ICM)Medtronic, Inc.Mar 28, 2024Special
K233562LINQ II Insertable Cardiac MonitorMedtronic, Inc.Dec 6, 2023Special
K233320LINQ II™ Insertable Cardiac Monitor (LNQ22)Medtronic, Inc.Oct 31, 2023Special
K231328LUX-Dx II (M302); LUX-Dx II+ (M312)Boston Scientific CorpAug 19, 2023Traditional
K230375BIOMONITOR IVBiotronik, Inc.May 19, 2023Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 34 with a free account)

Clearances by year

34 MXD 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)229
2025336
2024115
2023676
2022241
2021457
20204127
20191122
2017452
2016363
20152124
20142216

Who submits

6 applicants cleared a MXD device since 2011. 100% of the clearances went to applicants in United States. By type: Traditional 56% and Special 44%.

ApplicantClearances since 2011
Medtronic, Inc.17
Biotronik, Inc.11
Boston Scientific Corporation3
Abbott1
ABBOTT MEDICAL1
Boston Scientific Corp1

How FDA classifies it

Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.

From 21 CFR 870.1025. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 870.1025 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent MXD clearances declared.

Ask about MXD

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about MXD

What is FDA product code MXD?

Product code MXD, “Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection)” in FDA's classification database, is a Class II device type under 21 CFR 870.1025 (arrhythmia detector and alarm (including ST-segment measurement and alarm)), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 34 clearances under MXD, 34 of them since 2011.

How many 510(k) clearances are there under MXD?

FDA’s 510(k) database listed 34 clearances under MXD as of Oct 29, 2026, 34 of them decided since 2011; the most recent decision was Aug 28, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a MXD 510(k)?

For the 5 MXD clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 30 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most MXD clearances?

Since 2011: Medtronic, Inc. (17), Biotronik, Inc. (11), Boston Scientific Corporation (3), Abbott (1) and ABBOTT MEDICAL (1). 6 applicants have cleared a MXD device in that time.

Sources

  1. FDA product classification: MXD · Product Classification database
  2. 21 CFR 870.1025: Arrhythmia detector and alarm (including ST-segment measurement and alarm) · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for MXD · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow MXDGet an email when FDA clears, recalls or publishes guidance for MXD devices.

Know what FDA already cleared.